Creatine supplementation increases the ability of human dendritic cells derived from monocytes to activate T cells that recognize tumor antigens in laboratory cell cultures.
See the scientific wording
Creatine supplementation enhances the activation and tumor antigen-specific T cell priming capacity of human monocyte-derived dendritic cells in vitro.
Correlational — new studies may shift this
ObservationalOne moderate-quality study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
Cohort StudyHuman2026
Adding creatine to human immune cells in the lab made them better at teaching T cells to recognize and attack cancer cells, just like the claim says. This suggests creatine might help improve cancer immunotherapy.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Dendritic cells take in creatine when they are activated, convert it into a storage form that holds energy, and use that stored energy to keep their power supply stable. This stable power allows them to keep turning on a key signaling system that makes them more active and better at alerting T cells to attack cancer cells. As a result, the T cells multiply more, release more attack signals, and become more effective at finding and killing tumor cells.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Creatine supplementation increases the ability of human dendritic cells derived from monocytes to activate T cells that recognize tumor antigens in laboratory cell cultures.
Mechanism
1 studyDendritic cells use creatine to store energy, which keeps them powered up long enough to fully activate and send strong signals to T cells. This makes the T cells better at finding and killing cancer cells.
Dendritic cells take in creatine when they are activated, convert it into a storage form that holds energy, and use that stored energy to keep their power supply stable. This stable power allows them to keep turning on a key signaling system that makes them more active and better at alerting T cells to attack cancer cells. As a result, the T cells multiply more, release more attack signals, and become more effective at finding and killing tumor cells.
Dendritic cells increase expression of the creatine transporter protein in response to inflammatory signals such as TLR ligands or cytokines
Creatine enters the dendritic cells through the transporter and is converted into phosphocreatine, forming a high-energy phosphate reservoir
The phosphocreatine system maintains intracellular ATP levels during periods of high energy demand, preventing depletion and keeping AMP:ATP and ADP:ATP ratios low
Sustained ATP availability enables continuous activation of the NF-κB signaling pathway, including phosphorylation of IKKβ, IκBα, and p65, and nuclear translocation of p65
Activated NF-κB increases transcription of genes encoding costimulatory molecules (CD80, CD86, I-Ab) and proinflammatory cytokines (TNF-α, IL-6, IL-1β)
Dendritic cells with enhanced activation markers and cytokine secretion more effectively stimulate tumor antigen-specific CD8+ T cells, increasing their proliferation, cytokine production (IFN-γ, IL-2), and expression of activation markers (CD25, CD69)
Evidence from Studies
Supporting (1)
Community contributions welcome
Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
Adding creatine to human immune cells in the lab made them better at teaching T cells to recognize and attack cancer cells, just like the claim says. This suggests creatine might help improve cancer immunotherapy.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Creatine Supplementation Effects on Dendritic Cell Function and T Cell Priming in Human In Vitro Models
Systematic review and meta-analysis of all published in vitro studies using human monocyte-derived dendritic cells exposed to creatine versus control, measuring T cell activation markers and antigen-specific priming efficiency.
Randomized Controlled Trial of Creatine vs Placebo on Human Monocyte-Derived Dendritic Cell Function in Ex Vivo Culture
Randomized, double-blind, placebo-controlled in vitro experiment using monocyte-derived dendritic cells from healthy human donors, with creatine or vehicle added to culture media, measuring T cell priming via flow cytometry and cytokine release over 72 hours.
Cohort Study of Creatine Supplementation and Dendritic Cell Function in Healthy Human Volunteers Over 4 Weeks
Prospective cohort study following healthy human adults receiving daily creatine supplementation (5g/day) for 4 weeks, with serial blood draws to isolate monocytes, differentiate into dendritic cells, and measure T cell priming capacity ex vivo.
In Vitro Study of Creatine on Human Monocyte-Derived Dendritic Cell Activation and T Cell Priming
Single-center in vitro experiment exposing human monocyte-derived dendritic cells to varying concentrations of creatine (0–10 mM) for 24–72 hours, followed by co-culture with autologous T cells and measurement of CD69, IFN-γ, and proliferation.
Expert Opinion on the Translational Potential of Creatine for Cancer Immunotherapy Based on In Vitro Dendritic Cell Data
Narrative review or expert commentary by immunologists and oncologists discussing the biological plausibility and clinical implications of creatine's in vitro effects on dendritic cells.